FDA Inspection 1024833 — Danville Regional Medical Center/Blood Bank

Danville Regional Medical Center/Blood Bank — FEI 1171317

The FDA completed an inspection of Danville Regional Medical Center/Blood Bank on August 11, 2017 in Danville, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Danville, VA (United States)